Skip to content

Application research of artificial intelligence model based on radiomics in cerebral hemorrhage risk assessment and antithrombotic strategy management in elderly patients with cerebral microbleeds

Application research of artificial intelligence model based on radiomics in cerebral hemorrhage risk assessment and antithrombotic strategy management in elderly patients with cerebral microbleeds

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066235
Enrollment
Unknown
Registered
2022-11-29
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral vascular disease

Interventions

Observation modeling group:N/A
History Control Group:Multidisciplinary antithrombotic management

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age>=60 years old 2. At least one cerebral microbleeds detected by brain susceptibility weighted imaging 3. Patients who sign the informed consent form voluntarily and agree to be followed up

Exclusion criteria

Exclusion criteria: 1. Unable to undergo MRI due to contraindications; 2. Have intracranial vascular malformation,aneurysmbrain tumors or severe brain trauma; 3. Terminal cancer with life expectancy less than six months; 4. Unable to complete clinical follow-up.

Design outcomes

Primary

MeasureTime frame
Stroke, acute coronary syndrome and death;

Secondary

MeasureTime frame
Proportion of patients with increased number of cerebral microbleeds;

Countries

China

Contacts

Public ContactYinhong Liu

Beijing Hospital

liuyh302@126.com13681158470

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026